Didier Lardinois
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Didier Lardinois has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Alfred Zippelius
Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland
22 shared publications - Heinz Läubli
Division of Medical Oncology, University Hospital Basel, Basel, Switzerland
20 shared publications - Andreas Zingg
Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland
18 shared publications - Frank Stenner
Department of Oncology, University Hospital Basel, Basel, Switzerland
18 shared publications - Michael T. Sandholzer
Department of Biomedicine, University Hospital Basel and University of Basel, Switzerland
18 shared publications - Natalia Rodrigues Mantuano
Department of Biomedicine, University Hospital and University of Basel, Switzerland
18 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
Early complications after surgical stabilization of rib fractures: A retrospective cohort study
BACKGROUND: In recent years, interest in SSRF has increased due to the growing evidence of improved pain control, quality of life, and chest wall function. This study aimed to assess the incidence and the types of early complications (in-hospital and until 3 mo postoperatively) following SSRF and to develop a risk prediction score based on potential risk factors for complications. METHODS: We conducted a retrospective single-center analysis including 554 patients who underwent SSRF between 2008 and 2023. Data were extracted from electronic medical records and included demographic, trauma-related, and surgical variables, as well as characteristics of complications. Logistic regressions and risk prediction analyses were performed for in-hospital complications. RESULTS: The main indication for SSRF was a displaced, painful series of fractures (76%). Complications occurred in 33% of patients during hospitalization and in 9% between discharge and three months postoperatively. In-hospital complications were predominantly grade Clavien-Dindo I (12%) and II (22%), whereas the most frequent grades within the postdischarge complications were I and IIIB (both 3%). Both in-hospital and postdischarge complications were mainly pulmonary and thoracic (18% and 5%) in origin. In univariate analysis, age, ASA, number of fractured and fixed ribs, flail chest, and Charlson Comorbidity Index were independent risk factors for any complication. In multivariate analysis, ASA and flail chest were the only independent factors. A risk prediction model showed a complication risk of 18% in patients with no flail chest, ASA ≤II, and age <75 years, compared with 65% in patients with flail chest, ASA ≥IV and age ≥75. CONCLUSIONS: Early complications following SSRF are not rare but mostly minor. However, careful operation indication and perioperative management are particularly important in older, frail patients to avoid or reduce the risk of high-grade complications. LEVEL OF EVIDENCE: Therapeutic, Care Management; Level III.
- 1 October 2026
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
Open AccessEarly complications after surgical stabilization of rib fractures: A retrospective cohort study
BACKGROUND: In recent years, interest in SSRF has increased due to the growing evidence of improved pain control, quality of life, and chest wall function. This study aimed to assess the incidence and the types of early complications (in-hospital and until 3 mo postoperatively) following SSRF and to develop a risk prediction score based on potential risk factors for complications. METHODS: We conducted a retrospective single-center analysis including 554 patients who underwent SSRF between 2008 and 2023. Data were extracted from electronic medical records and included demographic, trauma-related, and surgical variables, as well as characteristics of complications. Logistic regressions and risk prediction analyses were performed for in-hospital complications. RESULTS: The main indication for SSRF was a displaced, painful series of fractures (76%). Complications occurred in 33% of patients during hospitalization and in 9% between discharge and three months postoperatively. In-hospital complications were predominantly grade Clavien-Dindo I (12%) and II (22%), whereas the most frequent grades within the postdischarge complications were I and IIIB (both 3%). Both in-hospital and postdischarge complications were mainly pulmonary and thoracic (18% and 5%) in origin. In univariate analysis, age, ASA, number of fractured and fixed ribs, flail chest, and Charlson Comorbidity Index were independent risk factors for any complication. In multivariate analysis, ASA and flail chest were the only independent factors. A risk prediction model showed a complication risk of 18% in patients with no flail chest, ASA ≤II, and age <75 years, compared with 65% in patients with flail chest, ASA ≥IV and age ≥75. CONCLUSIONS: Early complications following SSRF are not rare but mostly minor. However, careful operation indication and perioperative management are particularly important in older, frail patients to avoid or reduce the risk of high-grade complications. LEVEL OF EVIDENCE: Therapeutic, Care Management; Level III.
- Open Access
- 11 June 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (2) , 440-449
Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: secondary analysis of two prospective observational cohort studies
- 11 June 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (2) , 440-449
Open AccessPerioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: secondary analysis of two prospective observational cohort studies
- Open Access
- 4 April 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (4)
Prevalence and prognostic relevance of perioperative myocardial injury/infarction after major noncardiac surgery in older patients
Background: The prognostic relevance of perioperative myocardial injury/infarction (PMI) in older patients undergoing major noncardiac surgery remains unclear, as high comorbidity burden may lessen its impact. Methods: Older patients (defined as age ≥70 years with ≥3 comorbidities, or ≥80 years) enrolled in a multicentre, prospective study of patients at increased cardiovascular risk undergoing major noncardiac surgery were analysed. The primary endpoint, all-cause mortality at 1 year, was analysed using Cox proportional hazards regression. Secondary endpoints included major adverse cardiac events (MACE) (cardiovascular death, acute myocardial infarction, life-threatening arrhythmia and acute heart failure), analysed using Fine–Grey hazard regression. All models were adjusted for prespecified confounders with PMI as a time-varying exposure. Results: Amongst 4634 older patients (median age 80 years; 42.9% women), PMI occurred in 892 patients (19.2%), which was higher than in younger patients (P < .0001). The distribution of PMI aetiologies was comparable between groups. At 1 year, all-cause mortality was 26.2% in patients with PMI and 13.2% in patients without PMI, and MACE occurred in 30% versus 13%, respectively. After multivariable adjustment, the hazard ratio of PMI was highest on postoperative day 1 (all-cause mortality: 10.5 [95% CI 4.5–24.5]; MACE: 4.4 [95% CI 3.2–5.9]), declined by day 90 (1.4 [95% CI 1.0–1.9] and 2.2 [95% CI 1.7–2.7], respectively), and persisted through 1 year. Conclusions: PMI was very common amongst older patients and associated with substantially higher 1-year risks of all-cause mortality and MACE, with greatest vulnerability observed during the initial 90 postoperative days.
- 4 April 2026
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 55 (4)
Open AccessPrevalence and prognostic relevance of perioperative myocardial injury/infarction after major noncardiac surgery in older patients
Background: The prognostic relevance of perioperative myocardial injury/infarction (PMI) in older patients undergoing major noncardiac surgery remains unclear, as high comorbidity burden may lessen its impact. Methods: Older patients (defined as age ≥70 years with ≥3 comorbidities, or ≥80 years) enrolled in a multicentre, prospective study of patients at increased cardiovascular risk undergoing major noncardiac surgery were analysed. The primary endpoint, all-cause mortality at 1 year, was analysed using Cox proportional hazards regression. Secondary endpoints included major adverse cardiac events (MACE) (cardiovascular death, acute myocardial infarction, life-threatening arrhythmia and acute heart failure), analysed using Fine–Grey hazard regression. All models were adjusted for prespecified confounders with PMI as a time-varying exposure. Results: Amongst 4634 older patients (median age 80 years; 42.9% women), PMI occurred in 892 patients (19.2%), which was higher than in younger patients (P < .0001). The distribution of PMI aetiologies was comparable between groups. At 1 year, all-cause mortality was 26.2% in patients with PMI and 13.2% in patients without PMI, and MACE occurred in 30% versus 13%, respectively. After multivariable adjustment, the hazard ratio of PMI was highest on postoperative day 1 (all-cause mortality: 10.5 [95% CI 4.5–24.5]; MACE: 4.4 [95% CI 3.2–5.9]), declined by day 90 (1.4 [95% CI 1.0–1.9] and 2.2 [95% CI 1.7–2.7], respectively), and persisted through 1 year. Conclusions: PMI was very common amongst older patients and associated with substantially higher 1-year risks of all-cause mortality and MACE, with greatest vulnerability observed during the initial 90 postoperative days.
- Open Access
- 5 March 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (4)
Efficacy of Non-Powered Stapler in Lung Volume Reduction Surgery of Severe Lung Emphysema: A Prospective Randomized Single-Blinded Monocentric Study
Objectives: This study aimed to assess whether the use of the non-powered AEON Endostapler during lung resection in patients with severe lung emphysema reduces the duration of postoperative air leak, as measured by the air leak volume over time, in comparison to the Echelon Flex Powered Plus Stapler. Methods: A total of 32 lung volume reduction surgeries were performed on 19 patients, stratified by side of the operation. These procedures were randomly assigned to utilize either the non-powered or the powered stapler. Postoperative air leak was monitored using a digital recording system. The time to air leak closure, the incidence and severity of air leaks, and the duration of chest tube placement were evaluated. Results: Immediate postoperative air leaks were observed in 6 of 17 procedures (35.3%) using the non-powered stapler and in 9 of 15 procedures (60%) performed with the powered stapler. The median time to closure of the air leak was also considerably shorter in the non-powered procedures: 14.3 hours [6.7, 116] compared to 93.2 hours [2.1, 159] for the powered treatments. Cox regression analysis yielded a hazard ratio of 1.6 (95% CI, 0.73-3.3) for a faster air leak closure with the non-powered stapler (P = .25). Conclusions: Both stapler systems are feasible for use in patients with severe lung emphysema. However, our results show an earlier air leak closure and a lower incidence of postoperative air leaks with the use of a non-powered stapler. Clinical registration number: https://clinicaltrials.gov/study/NCT05628415? term=LVRS&rank=9, 28.11.2022
- 5 March 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (4)
Open AccessEfficacy of Non-Powered Stapler in Lung Volume Reduction Surgery of Severe Lung Emphysema: A Prospective Randomized Single-Blinded Monocentric Study
Objectives: This study aimed to assess whether the use of the non-powered AEON Endostapler during lung resection in patients with severe lung emphysema reduces the duration of postoperative air leak, as measured by the air leak volume over time, in comparison to the Echelon Flex Powered Plus Stapler. Methods: A total of 32 lung volume reduction surgeries were performed on 19 patients, stratified by side of the operation. These procedures were randomly assigned to utilize either the non-powered or the powered stapler. Postoperative air leak was monitored using a digital recording system. The time to air leak closure, the incidence and severity of air leaks, and the duration of chest tube placement were evaluated. Results: Immediate postoperative air leaks were observed in 6 of 17 procedures (35.3%) using the non-powered stapler and in 9 of 15 procedures (60%) performed with the powered stapler. The median time to closure of the air leak was also considerably shorter in the non-powered procedures: 14.3 hours [6.7, 116] compared to 93.2 hours [2.1, 159] for the powered treatments. Cox regression analysis yielded a hazard ratio of 1.6 (95% CI, 0.73-3.3) for a faster air leak closure with the non-powered stapler (P = .25). Conclusions: Both stapler systems are feasible for use in patients with severe lung emphysema. However, our results show an earlier air leak closure and a lower incidence of postoperative air leaks with the use of a non-powered stapler. Clinical registration number: https://clinicaltrials.gov/study/NCT05628415? term=LVRS&rank=9, 28.11.2022
- Top Cited Papers
- 30 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (12) , 1470-1483
Peri-operative myocardial infarction/injury after non-cardiac surgery: association between cardiologist evaluation and outcomes
Background and Aims: Peri-operative myocardial infarction/injury (PMI) is a common cardiac complication following non-cardiac surgery. It remains unclear whether involvement of cardiologists in the management of patients developing PMI improves outcomes. Methods: This multicentre, prospective study included high-risk patients undergoing non-cardiac surgery, eligible for the institutional PMI active surveillance and response programme. Due to staffing constraints, cardiologist evaluation of patients with PMI was inconsistently available on weekends, on public holidays, or when care for more urgent patients had to be prioritized, allowing a comparison between patients receiving cardiologist evaluation and those who did not. The primary endpoint was major adverse cardiac events, defined as a composite of cardiovascular death, myocardial infarction, acute heart failure, and life-threatening arrhythmia at 365 days. The secondary endpoint was all-cause death at 365 days. Cox proportional hazards models were used to evaluate the association between cardiologist evaluation and outcomes. Results: Among 14 294 patients, 1048 developed PMI and were eligible for this analysis, of whom 614 patients (58.6%) received post-operative cardiologist evaluation. Baseline characteristics were similar between groups. After adjustment, cardiologist evaluation was independently associated with lower risk of major adverse cardiac events (adjusted hazard ratio .54, P = .001) and all-cause death (adjusted hazard ratio .65, P = .037) at 365 days. Sensitivity analyses confirmed these findings. Patients receiving cardiology evaluation were more likely to undergo non-invasive cardiac imaging and to receive dual antiplatelet and statin therapy. Conclusions: Cardiologist evaluation of patients with PMI following major non-cardiac surgery was associated with a reduced risk of major adverse cardiac events and all-cause mortality at 365 days after surgery, suggesting that interdisciplinary management may improve post-operative outcomes.
- 30 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (12) , 1470-1483
Top Cited PapersPeri-operative myocardial infarction/injury after non-cardiac surgery: association between cardiologist evaluation and outcomes
Background and Aims: Peri-operative myocardial infarction/injury (PMI) is a common cardiac complication following non-cardiac surgery. It remains unclear whether involvement of cardiologists in the management of patients developing PMI improves outcomes. Methods: This multicentre, prospective study included high-risk patients undergoing non-cardiac surgery, eligible for the institutional PMI active surveillance and response programme. Due to staffing constraints, cardiologist evaluation of patients with PMI was inconsistently available on weekends, on public holidays, or when care for more urgent patients had to be prioritized, allowing a comparison between patients receiving cardiologist evaluation and those who did not. The primary endpoint was major adverse cardiac events, defined as a composite of cardiovascular death, myocardial infarction, acute heart failure, and life-threatening arrhythmia at 365 days. The secondary endpoint was all-cause death at 365 days. Cox proportional hazards models were used to evaluate the association between cardiologist evaluation and outcomes. Results: Among 14 294 patients, 1048 developed PMI and were eligible for this analysis, of whom 614 patients (58.6%) received post-operative cardiologist evaluation. Baseline characteristics were similar between groups. After adjustment, cardiologist evaluation was independently associated with lower risk of major adverse cardiac events (adjusted hazard ratio .54, P = .001) and all-cause death (adjusted hazard ratio .65, P = .037) at 365 days. Sensitivity analyses confirmed these findings. Patients receiving cardiology evaluation were more likely to undergo non-invasive cardiac imaging and to receive dual antiplatelet and statin therapy. Conclusions: Cardiologist evaluation of patients with PMI following major non-cardiac surgery was associated with a reduced risk of major adverse cardiac events and all-cause mortality at 365 days after surgery, suggesting that interdisciplinary management may improve post-operative outcomes.
- Open Access
- 24 December 2025
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (2) , 499-501
Surgery After Microcoil Embolization in a Patient With Large Bilateral Intrathoracic Extramedullary Hematopoiesis and Thalassemia
- 24 December 2025
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (2) , 499-501
Open AccessSurgery After Microcoil Embolization in a Patient With Large Bilateral Intrathoracic Extramedullary Hematopoiesis and Thalassemia
- Open Access
- 8 August 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (8) , 364
Estimating Postoperative Lung Function Using Three-Dimensional Segmental HRCT-Reconstruction: A Retrospective Pilot Study on Right Upper Lobe Resections
Background/Objectives: Can three-dimensional (3D) reconstruction software that simulates postoperative lung volumes more effectively identify suitable candidates for anatomical lung resection compared to conventional methods, particularly in personalized surgical planning? Patients/Methods: This single-center pilot study included 20 patients (10 females; age 68 ± 10 years) who underwent segmental or lobar VATS resection of the right upper lobe for NSCLC. Three-dimensional simulations from preoperative HRCT scans were correlated with measured pulmonary function and compared with predictions from the “5% per segment rule” and the model proposed by Brunelli et al. Results: Patients (8/20) with increased postoperative FEV1 [2.40 (0.56) vs. 2.30 (0.55)] had a lower proportion of healthy tissue [76 (18)% vs. 89 (10)%, p = 0.045] in 3D simulations than those with decreased FEV1. Mean postoperative FEV1 was 2.3 (0.54); the Brunelli model predicted 1.8 (0.36) and the “5% rule” 2.2 (0.54). Both models underestimated postoperative function, though the “5% rule” was more accurate. Conclusions: This pilot study suggests that 3D-HRCT reconstruction has the potential to facilitate patient-tailored identification of individuals who may derive greater benefit from surgical intervention compared to conventional methods. Further research is needed to determine whether this technology can more accurately predict postoperative pulmonary function in patients with severe COPD. Utilizing 3D-segmental-HRCT-reconstruction software, the advantages of lung resection in the context of NSCLC can be assessed on an individualized patient basis.
- 8 August 2025
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 15 (8) , 364
Open AccessEstimating Postoperative Lung Function Using Three-Dimensional Segmental HRCT-Reconstruction: A Retrospective Pilot Study on Right Upper Lobe Resections
Background/Objectives: Can three-dimensional (3D) reconstruction software that simulates postoperative lung volumes more effectively identify suitable candidates for anatomical lung resection compared to conventional methods, particularly in personalized surgical planning? Patients/Methods: This single-center pilot study included 20 patients (10 females; age 68 ± 10 years) who underwent segmental or lobar VATS resection of the right upper lobe for NSCLC. Three-dimensional simulations from preoperative HRCT scans were correlated with measured pulmonary function and compared with predictions from the “5% per segment rule” and the model proposed by Brunelli et al. Results: Patients (8/20) with increased postoperative FEV1 [2.40 (0.56) vs. 2.30 (0.55)] had a lower proportion of healthy tissue [76 (18)% vs. 89 (10)%, p = 0.045] in 3D simulations than those with decreased FEV1. Mean postoperative FEV1 was 2.3 (0.54); the Brunelli model predicted 1.8 (0.36) and the “5% rule” 2.2 (0.54). Both models underestimated postoperative function, though the “5% rule” was more accurate. Conclusions: This pilot study suggests that 3D-HRCT reconstruction has the potential to facilitate patient-tailored identification of individuals who may derive greater benefit from surgical intervention compared to conventional methods. Further research is needed to determine whether this technology can more accurately predict postoperative pulmonary function in patients with severe COPD. Utilizing 3D-segmental-HRCT-reconstruction software, the advantages of lung resection in the context of NSCLC can be assessed on an individualized patient basis.
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (6) , 3981-3990
Clinical and surgical outcome following chest wall reconstruction using a novel rigid prosthesis—a single-center experience
Background: For various reasons, a chest wall resection may be necessary. Large defects in the chest wall and sternum require reconstruction to avoid paradoxical, inadequate breathing, protect underlying structures, and achieve a good functional result. Codubix®Ribs is a prosthesis made of polyester and polypropylene yarn, which has been recently introduced for reconstruction. Our objective was to evaluate the integrity of the chest wall and the occurrence of pain in patients who underwent resection of the chest wall and/or sternum followed by reconstruction with Codubix®Ribs. Methods: We postoperatively collected data from eleven patients (mean age 53 years) who underwent chest wall reconstruction with Codubix®Ribs between 2019 and 2023. At a prospective visit, pain was assessed using the numeric rating scale (NRS). Functionality was measured by assessing upper extremity mobility (QuickDASH questionnaire; 0 being the best, 100 the worst), clinical examination, and by time resolved dynamic (cine) magnetic resonance imaging (MRI). Results: Indications for resection were tumors (n=9) and osteomyelitis (n=2) in anterior (n=2), anterolateral (n=7), lateral (n=1), and posterolateral (n=1) locations. The sternum was involved in three patients. Complications included one patient with dislocation due to an initially undersized prosthesis, which was followed by an uneventful reoperation. Functional assessment was performed on nine patients at a median follow-up time of 11 (5.75, 49.5) months. The mean NRS pain score was 1.7±2.2, and the median QuickDASH score was of 6.8. The chest wall was stable in all patients. Dynamic MRI showed symmetric chest wall movement in all but two patients, without observation of paradoxical motion. Conclusions: We observed excellent functional results using Codubix®Ribs for chest wall reconstruction, indicating high stability and low complication rates. However, further studies involving a greater number of patients are required to confirm our initial findings.
- 1 June 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (6) , 3981-3990
Open AccessClinical and surgical outcome following chest wall reconstruction using a novel rigid prosthesis—a single-center experience
Background: For various reasons, a chest wall resection may be necessary. Large defects in the chest wall and sternum require reconstruction to avoid paradoxical, inadequate breathing, protect underlying structures, and achieve a good functional result. Codubix®Ribs is a prosthesis made of polyester and polypropylene yarn, which has been recently introduced for reconstruction. Our objective was to evaluate the integrity of the chest wall and the occurrence of pain in patients who underwent resection of the chest wall and/or sternum followed by reconstruction with Codubix®Ribs. Methods: We postoperatively collected data from eleven patients (mean age 53 years) who underwent chest wall reconstruction with Codubix®Ribs between 2019 and 2023. At a prospective visit, pain was assessed using the numeric rating scale (NRS). Functionality was measured by assessing upper extremity mobility (QuickDASH questionnaire; 0 being the best, 100 the worst), clinical examination, and by time resolved dynamic (cine) magnetic resonance imaging (MRI). Results: Indications for resection were tumors (n=9) and osteomyelitis (n=2) in anterior (n=2), anterolateral (n=7), lateral (n=1), and posterolateral (n=1) locations. The sternum was involved in three patients. Complications included one patient with dislocation due to an initially undersized prosthesis, which was followed by an uneventful reoperation. Functional assessment was performed on nine patients at a median follow-up time of 11 (5.75, 49.5) months. The mean NRS pain score was 1.7±2.2, and the median QuickDASH score was of 6.8. The chest wall was stable in all patients. Dynamic MRI showed symmetric chest wall movement in all but two patients, without observation of paradoxical motion. Conclusions: We observed excellent functional results using Codubix®Ribs for chest wall reconstruction, indicating high stability and low complication rates. However, further studies involving a greater number of patients are required to confirm our initial findings.
- Open Access
- 29 April 2025
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 51 (1) , 1-14
Long-term outcomes after removal of rib stabilization hardware in patients with blunt chest trauma
Purpose: The study aim was to investigate the long-term outcomes after hardware removal (HR) in patients with blunt chest trauma. We hypothesized that HR might be beneficial in indicated patients to improve patient health. Methods: We performed a retrospective single-center study between 2017 and 2023. Descriptive statistics were used for the analysis. One study-specific follow-up visit was conducted, 28 months (range 3–72) after HR. The study-specific health survey used, consisted of four functional dimensions (mobility, self-care, usual activities, mental health) and two symptom dimensions (thoracic pain, chest tightness) which were rated on a numerical scale and compared to the status before HR in four categories (much better to worse). Results: Of the 28 patients, the average age was 59 years (range 29–83), 12 fractures (1–39) were fixed, and 4 implants (1–11) were used. The indications for HR were persistent thoracic pain (36%), discomfort (25%), chest tightness (21%), hardware dislocation (11%) and hardware infection (7%). HR was performed 18 months (5 days-104 months) after surgery for trauma. Patients with chest tightness and infection exhibited the greatest improvement in symptoms (75%), followed by those with hardware dislocation (61%). The improvement rate in the other 2 groups was 58%. All patients who experienced chest tightness, hardware dislocation and infection were completely satisfied and would undergo HR again. Conclusion: HR is safe and feasible, resulting in significant symptom relief and improvement in health status in approximately two-thirds of patients. In indicated patients, HR might be performed earlier and more liberally if symptoms are disabling. Clinical trial registration number: NCT06003595 registered on July 18, 2023.
- 29 April 2025
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 51 (1) , 1-14
Open AccessLong-term outcomes after removal of rib stabilization hardware in patients with blunt chest trauma
Purpose: The study aim was to investigate the long-term outcomes after hardware removal (HR) in patients with blunt chest trauma. We hypothesized that HR might be beneficial in indicated patients to improve patient health. Methods: We performed a retrospective single-center study between 2017 and 2023. Descriptive statistics were used for the analysis. One study-specific follow-up visit was conducted, 28 months (range 3–72) after HR. The study-specific health survey used, consisted of four functional dimensions (mobility, self-care, usual activities, mental health) and two symptom dimensions (thoracic pain, chest tightness) which were rated on a numerical scale and compared to the status before HR in four categories (much better to worse). Results: Of the 28 patients, the average age was 59 years (range 29–83), 12 fractures (1–39) were fixed, and 4 implants (1–11) were used. The indications for HR were persistent thoracic pain (36%), discomfort (25%), chest tightness (21%), hardware dislocation (11%) and hardware infection (7%). HR was performed 18 months (5 days-104 months) after surgery for trauma. Patients with chest tightness and infection exhibited the greatest improvement in symptoms (75%), followed by those with hardware dislocation (61%). The improvement rate in the other 2 groups was 58%. All patients who experienced chest tightness, hardware dislocation and infection were completely satisfied and would undergo HR again. Conclusion: HR is safe and feasible, resulting in significant symptom relief and improvement in health status in approximately two-thirds of patients. In indicated patients, HR might be performed earlier and more liberally if symptoms are disabling. Clinical trial registration number: NCT06003595 registered on July 18, 2023.